This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A T-cell therapy developed by Orca Bio, a private biotech company, significantly...
“Nobody complains that we have more cancer medicines available today than in the...
While organizations invest millions in advanced medical technologies, their appr...
The competition between U.S. and Chinese biotech companies is particularly fierc...
Stanford researchers have developed a new tool to evaluate AI language models fo...
Banning FDA ad-comm members who have any conflict of interest might sound good, ...
In this edition of STAT's Health Tech newsletter: Medical device makers file saf...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pi...
The White House has pulled the nomination of Dave Weldon as CDC director hours b...
The U.K. government proposes raising mandatory drug rebates paid by drug compani...
The U.K. government proposes raising mandatory drug rebates paid by drug compani...
“There is a pervasive sense of fear — of losing access to critical health care s...
As the NIH braces for cuts of up to 5,000 of its 20,000 positions, “people are s...
Oz mentioned risk coding and prior authorizations as areas he plans to examine i...
RFK Jr.’s recent roundtable on regenerative medicine offers some worrying signs ...
In today's Pharmalittle roundup, an FDA office crunch, Trump's health agency pic...
Want to stay on top of the science and politics driving biotech today? Sign up t...
RFK Jr.'s claims on the safety of vaccine safety aren't backed by the data.
RFK Jr.'s claims on the safety of vaccine safety aren't backed by the data.
Huseyin Zeyd Koytak and his colleagues analyzed 50 million vaccine-related socia...
Banning FDA ad-comm members who have any conflict of interest might sound good, ...
RFK Jr.'s claims on the safety of vaccine safety aren't backed by the data.
A new report explores possible best practices for the adoption, use and monitori...